New weapon tested in fight against tough cancers
Disease control
Ongoing
This early-stage study is testing a new drug, ICT01, in people with advanced cancers that have come back or stopped responding to other treatments. Researchers want to see if ICT01 is safe, both on its own and when combined with an existing immunotherapy drug (Keytruda). They wil…
Phase: PHASE1, PHASE2 • Sponsor: ImCheck Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC